HMB-002 (Part A)
HMB-002-102
Phase 2 small_molecule active
Quick answer
HMB-002 (Part A) for Von Willebrand Disease (VWD) is a Phase 2 program (small_molecule) at Hemab Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hemab Therapeutics Holdings
- Indication
- Von Willebrand Disease (VWD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active